Centuri Holdings, Inc. financials

CTRI CIK 0001981599

Source: EDGAR filings · Built 2026-06-02T02:45:37Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2024
Free Cash Flow -17.62M 47.60M -46.95M
EBITDA 231.61M 222.13M 53.92M
Working Capital 384.98M 219.06M
Net Debt 811.48M 959.64M
Gross Margin 8.27% 8.37% 7.77%
Operating Margin 3.11% 3.29% -3.67%
Net Margin 0.75% -0.26% -6.09%
Return on Equity (ROE) 2.57% -1.21% -43.48%
Return on Assets (ROA) 0.93% -0.32%
Current Ratio 1.78× 1.57×
Debt-to-Equity 1.07× 1.82×
Effective Tax Rate -55.28% -103.28% -0.79%
Cash Conversion Ratio 3.49× -23.53× -0.56×
Accruals Ratio -0.02× -0.08×
SBC % of Revenue 0.27% 0.08% 0.06%
CapEx Coverage 0.82× 1.43× 0.67×
Free Cash Flow Per Share $-0.20 $0.57 $-0.66

Valuation Metrics

Concept FY 2025FY 2024FY 2024
P/E Trailing (Diluted) 103.76×
P/FCF 34.57×
FCF Yield 2.89%
EV / EBITDA 14.78× 12.19×
P/S 0.88× 0.66×
P/B 2.99× 3.15×

Income Statement

Concept FY 2025FY 2024FY 2024
Revenue from Contract with Customer, Excluding Assessed Tax 2.98B 2.64B 2.76B
Cost of Goods and Services Sold 2.74B 2.42B 2.55B
Gross Profit 246.57M 220.67M 214.61M
Selling, General and Administrative Expense 126.46M 107.25M 109.20M
Operating Income (Loss) 92.82M 86.78M -101.43M
Income Tax Expense (Benefit) -8.06M 3.47M 1.30M
Net Income (Loss) Attributable to Parent 22.39M -6.72M -168.15M
Earnings Per Share, Basic $0.25 $-0.08 $-2.35
Weighted Average Number of Shares Outstanding, Basic 90.00M 83.29M 71.67M
Earnings Per Share, Diluted $0.25 $-0.08 $-2.35
Weighted Average Number of Shares Outstanding, Diluted 90.30M 83.29M 71.67M

Balance Sheet

Concept FY 2025FY 2024FY 2024
Cash and Cash Equivalents, at Carrying Value 126.63M 49.02M
Assets, Current 881.38M 601.38M
Assets 2.41B 2.07B
Liabilities, Current 496.39M 382.33M
Long-term Debt, Excluding Current Maturities 708.07M 843.86M
Liabilities 1.53B 1.51B
Stockholders' Equity Attributable to Parent 872.97M 555.55M 386.75M
Common Stock, Shares, Outstanding 100.72M 88.52M

Cash Flow Statement

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (CTRI CIK 0001981599), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

JOBY

Joby Aviation, Inc.

SKYE

Skye Bioscience, Inc.

BURL

BURLINGTON STORES, INC.